[go: up one dir, main page]

UA105827C2 - Normal;heading 1;heading 2;heading 3;HERAPEUTIC COMBINATION OF THEOBROMINE AND AN ANTIHISTAMINE ACTING ON H1-RECEPTOR - Google Patents

Normal;heading 1;heading 2;heading 3;HERAPEUTIC COMBINATION OF THEOBROMINE AND AN ANTIHISTAMINE ACTING ON H1-RECEPTOR

Info

Publication number
UA105827C2
UA105827C2 UAA201208623A UAA201208623A UA105827C2 UA 105827 C2 UA105827 C2 UA 105827C2 UA A201208623 A UAA201208623 A UA A201208623A UA A201208623 A UAA201208623 A UA A201208623A UA 105827 C2 UA105827 C2 UA 105827C2
Authority
UA
Ukraine
Prior art keywords
heading
antihistamine
theobromine
herapeutic
receptor
Prior art date
Application number
UAA201208623A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джон Брю
Робін Марк Банністер
Original Assignee
Байокоупі Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байокоупі Лімітед filed Critical Байокоупі Лімітед
Publication of UA105827C2 publication Critical patent/UA105827C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

An agent comprises theobromine and an antihistamine, as a combined preparation for simultaneous, sequential or separate use in therapy, particularly in the therapy of cough.
UAA201208623A 2009-12-14 2010-12-14 Normal;heading 1;heading 2;heading 3;HERAPEUTIC COMBINATION OF THEOBROMINE AND AN ANTIHISTAMINE ACTING ON H1-RECEPTOR UA105827C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
PCT/GB2010/052086 WO2011073647A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Publications (1)

Publication Number Publication Date
UA105827C2 true UA105827C2 (en) 2014-06-25

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201208623A UA105827C2 (en) 2009-12-14 2010-12-14 Normal;heading 1;heading 2;heading 3;HERAPEUTIC COMBINATION OF THEOBROMINE AND AN ANTIHISTAMINE ACTING ON H1-RECEPTOR

Country Status (18)

Country Link
EP (1) EP2512472A1 (en)
JP (2) JP2013513652A (en)
CN (1) CN102802625A (en)
AU (1) AU2010332495C1 (en)
BR (1) BR112012014159A8 (en)
CA (1) CA2784215A1 (en)
CO (1) CO6541638A2 (en)
GB (1) GB0921803D0 (en)
IL (1) IL220384A0 (en)
MX (1) MX2012006624A (en)
NZ (1) NZ600267A (en)
PE (1) PE20121538A1 (en)
PH (1) PH12012501200A1 (en)
RU (1) RU2012129675A (en)
SG (2) SG181603A1 (en)
UA (1) UA105827C2 (en)
WO (1) WO2011073647A1 (en)
ZA (1) ZA201204294B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
CN103263533B (en) * 2013-05-31 2014-11-05 杨宏伟 Theobromine composition for treating cough and application and preparation thereof
CN104188998A (en) * 2014-09-18 2014-12-10 中山大学 Naringin and fexofenadine hydrochloride drug composition and preparation thereof
CN104224819B (en) * 2014-09-18 2016-08-17 中山大学 A kind of naringin and levo-cetirizine hydrochloride pharmaceutical composition and preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2019634B3 (en) * 1986-04-17 1991-07-01 Alza Corp CHLORPHENIRAMINE THERAPY.
HUP9700654A2 (en) 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
JPH10316568A (en) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd Pharmaceutical composition
JP2003012514A (en) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd Pharmaceutical composition
JP2003128549A (en) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd Composition applicable to mucous membrane
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
EP2131834A2 (en) * 2007-04-11 2009-12-16 Alcon Research, Ltd. Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis

Also Published As

Publication number Publication date
PH12012501200A1 (en) 2012-11-26
ZA201204294B (en) 2013-02-27
AU2010332495A1 (en) 2012-06-21
MX2012006624A (en) 2012-10-05
JP2016040280A (en) 2016-03-24
NZ600267A (en) 2013-07-26
EP2512472A1 (en) 2012-10-24
SG181603A1 (en) 2012-07-30
CN102802625A (en) 2012-11-28
AU2010332495C1 (en) 2016-02-11
CO6541638A2 (en) 2012-10-16
WO2011073647A1 (en) 2011-06-23
JP2013513652A (en) 2013-04-22
BR112012014159A8 (en) 2017-12-26
CA2784215A1 (en) 2011-06-23
GB0921803D0 (en) 2010-01-27
AU2010332495B2 (en) 2015-01-22
SG10201408374WA (en) 2015-01-29
RU2012129675A (en) 2014-01-27
JP6078605B2 (en) 2017-02-08
BR112012014159A2 (en) 2017-08-29
IL220384A0 (en) 2012-08-30
PE20121538A1 (en) 2012-12-21

Similar Documents

Publication Publication Date Title
UA105827C2 (en) Normal;heading 1;heading 2;heading 3;HERAPEUTIC COMBINATION OF THEOBROMINE AND AN ANTIHISTAMINE ACTING ON H1-RECEPTOR
NZ619520A (en) Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
UA96124C2 (en) Pharmaceutical foam formulation copmprising imiquimod
AP2507A (en) Quinoline derivatives and use thereof as mycobacterial inhibitors.
SI2679676T1 (en) Methods and organisms for the growth-coupled production of 1,4-butanediol
WO2011127070A3 (en) IRE-1α INHIBITORS
IL180872A0 (en) Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv
WO2006011810A3 (en) Mr imaging method for the discrimination between healthy and tumour tissue
UA93903C2 (en) Tetrahydroisoquinoline derivatives to enhance memory function
WO2008089397A3 (en) Adrb2 cancer markers
MY148723A (en) Use of pinolenic acid for the treatment of obesity
PH12013500392A1 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy
PL2410047T3 (en) Oxidoreductase and its use for the reduction of secodione derivatives
WO2009149058A3 (en) Modified release niacin formulations
EP2033650A4 (en) Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor
WO2011058373A3 (en) Drug combination with theobromine and its use in therapy
WO2012054093A3 (en) Acyl piperidine inhibitors of soluble epoxide hydrolase
PH12012501203A1 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
PH12012500955A1 (en) Drug combination with theobromine and its use in therapy
TW200631584A (en) A medicament related to mirtazapine for the treatment of hot flush
GB201219334D0 (en) Catheter having inflation and deflation lumen useful for preventing or reducing reperfusion injury
MX2012005849A (en) Immunomodulatory compounds for the restoration of vitamin d sensitivity in vitamin d resistant tumor cells.
WO2012040444A3 (en) Treatment of patients with incipient alzheimer's disease
TW200635934A (en) Amorphous tacrolimus and preparation thereof
UA70710U (en) Method for preventing recurrence of allergodermatosis in patients with secondary immunodeficiencies